Cargando…
Cancer treatment-related neuropathic pain: proof of concept study with menthol—a TRPM8 agonist
PURPOSE: Effective treatment of neuropathic pain without unacceptable side effects is challenging. Cancer sufferers increasingly live with long-term treatment-related neuropathic pain, resulting from chemotherapy-induced peripheral neuropathy (CIPN) or surgical scars. This proof-of-concept study aim...
Autores principales: | Fallon, M. T., Storey, D. J., Krishan, A., Weir, C. J., Mitchell, R., Fleetwood-Walker, S. M., Scott, A. C., Colvin, L. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519585/ https://www.ncbi.nlm.nih.gov/pubmed/25680765 http://dx.doi.org/10.1007/s00520-015-2642-8 |
Ejemplares similares
-
Anti-hyperalgesic effects of a novel TRPM8 agonist in neuropathic rats: A comparison with topical menthol
por: Patel, Ryan, et al.
Publicado: (2014) -
A-Type GABA Receptor as a Central Target of TRPM8 Agonist Menthol
por: Zhang, Xiao-Bing, et al.
Publicado: (2008) -
Differential Activation of TRPM8 by the Stereoisomers of Menthol
por: Chen, Xiaoying, et al.
Publicado: (2022) -
Menthol Inhibits Detrusor Contractility Independently of TRPM8 Activation
por: Ramos-Filho, Antonio Celso Saragossa, et al.
Publicado: (2014) -
Activation of peripheral TRPM8 mitigates ischemic stroke by topically applied menthol
por: Huang, Shiang-Suo, et al.
Publicado: (2022)